A detailed history of Shelton Capital Management transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Shelton Capital Management holds 920 shares of MEDP stock, worth $320,601. This represents 0.01% of its overall portfolio holdings.

Number of Shares
920
Previous 920 -0.0%
Holding current value
$320,601
Previous $378,000 19.05%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$372.0 - $424.34 $36,084 - $41,160
-97 Reduced 9.54%
920 $378,000
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $29,805 - $40,961
-131 Reduced 11.41%
1,017 $311,000
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $21,760 - $26,195
-93 Reduced 7.49%
1,148 $277,000
Q2 2023

Aug 10, 2023

SELL
$187.26 - $240.17 $10,673 - $13,689
-57 Reduced 4.39%
1,241 $298,000
Q1 2023

May 11, 2023

BUY
$174.31 - $239.52 $2,266 - $3,113
13 Added 1.01%
1,298 $244,000
Q4 2022

Feb 13, 2023

SELL
$153.06 - $226.57 $19,897 - $29,454
-130 Reduced 9.19%
1,285 $272,000
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $16,544 - $20,803
-114 Reduced 7.46%
1,415 $222,000
Q1 2021

May 14, 2021

BUY
$132.02 - $168.26 $201,858 - $257,269
1,529 New
1,529 $251,000
Q4 2020

Feb 16, 2021

SELL
$109.38 - $149.19 $205,415 - $280,178
-1,878 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$92.95 - $130.61 $174,560 - $245,285
1,878 New
1,878 $210,000
Q1 2020

May 13, 2020

SELL
$61.71 - $101.95 $149,708 - $247,330
-2,426 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$70.08 - $84.64 $11,843 - $14,304
-169 Reduced 6.51%
2,426 $204,000
Q3 2019

Nov 13, 2019

BUY
$62.38 - $85.89 $161,876 - $222,884
2,595 New
2,595 $218,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.